Illegal drugs

The use of illicit drugs exposes individuals to various health, social, and legal risks. In light of this major public health issue, prevention is essential.

Our missions

  • To study the levels and patterns of illicit drug use, in partnership with the OFDT

  • Designing, promoting, and evaluating prevention programs

  • To inform, listen to, advise, and refer people who use drugs and their families and friends

  • To inform the general public, healthcare professionals, and public authorities

Publications

Here you will find the latest scientific publications related to the studies and research conducted by Santé publique France.

Refine by filters

Type of publications
Type de publication
Regions
Régions

150 publications

rapport/synthèse

Multicenter, multi-site study on the prevalence and determinants of practices that increase the risk of HIV and HCV transmission among people who use drugs (Coquelicot Study). Feasibility phase – January 2001–September 2002. Final report

rapport/synthèse

Contribution to the evaluation of harm reduction policy - SIAMOIS (Information System on Access to Pharmacy-Dispensed Injection and Substitution Supplies). Description, analysis, and interpretation of pharmacy sales data for syringes and substitution products in France from 1996 to 1999. Volume 2: A detailed approach for use by field workers

rapport/synthèse

Contribution to the evaluation of harm reduction policy - SIAMOIS (Information System on Access to Pharmacy-Dispensed Injection and Substitution Supplies). Description, analysis, and interpretation of pharmacy sales data for syringes and substitution products in France from 1996 to 1999. Volume 1: Major Trends